CA2434731C — Modular infusion device and method
Assigned to Insulet Corp · Expires 2010-01-26 · 16y expired
What this patent protects
A device (10) for delivering fluid including a disposable assembly (800) having an exit port assembly (70) and a metering portion of a dispenser (40) for controlling fluid flow to the exit port assembly (70), and a reusable assembly (700) having a control portion (46) of the disp…
USPTO Abstract
A device (10) for delivering fluid including a disposable assembly (800) having an exit port assembly (70) and a metering portion of a dispenser (40) for controlling fluid flow to the exit port assembly (70), and a reusable assembly (700) having a control portion (46) of the dispenser (40) adapted to control the metering portion of the dispenser (40) upon attachment of the reusable assembly (700) and the disposable assembly (800), a local processor (50) connected to the dispenser (40) and programmed to cause fluid flow to the exit port assembly (70) through the dispenser (40) based upon flow instructions, and a local wireless communication element (60) connected to the local processor (50) for receiving flow instructions from a remote wireless device (100). The assemblies (700, 800) are adapted to be removably attached, and a power source (80) is contained in the disposable assembly (800) for providing power to the reusable assembly (700) upon attachment of the reusable assembly (700) and the disposable assembly (800)..
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.